IP Snapshot - August 2009
Bringing you monthly news of key developments in
intellectual property law
TRADE MARKS
American Clothing Associates SA v OHIM and OHIM v
American Clothing Associates, Joined Cases C-202/08 P and C-208/08
P, 16 July 2009
The ECJ has held that the CFI was wrong to deny protection to
the Canadian national emblem of a maple leaf against registration
of the figurative mark for services. The ECJ found that Article 6
of the Paris Convention applied to service marks as well as trade
marks and therefore OHIM had been entitled to refuse registration
of the applicant's mark in relation to the services in class 40
for the same reason that it had refused registration for the goods
in classes 18 and 25. This shows the courts giving a purposive
interpretation of the legislations, that trade marks and service
marks are intended to be treated in the same way, rather than a
strict literal interpretation.
For the full text of the decision, click
here.
Nokia Corporation v Revenue & Customs [2009] EWHC
1903 (Ch), 27 July 2009
Nokia applied for a judicial review of Her Majesty's
Commissioners of Revenue and Customs' ("HMRC")
decision not to continue to detain or suspend the release of a
shipment of mobile phones and accessories, which Nokia believed to
be counterfeit. Its application has been refused.
For the full text of our Law-Now update on this, click
here.
(1) Whirlpool Corporation (2) Whirlpool Properties Inc.
(3) KitchenAid Europa Inc. v Kenwood Limited [2009] EWCA Civ 753,
23 July 2009
The Court of Appeal has upheld the High Court's decision
that there was no infringement under Article 9(1)(c) of the CTM
Regulation (40/94/EEC, now replaced by 2009/207/EC) as the
"kMix" mixer, although similar to the Claimants'
Community trade mark ("CTM"), was not taking unfair
advantage of or causing detriment to the distinctive character or
repute of the CTM.
For the full text of the decision, click
here.
PATENTS
Generics (UK) Limited v Daiichi Pharmaceutical Co Ltd
and another [2009] EWCA Civ 646, 2 July 2009
The Court of Appeal has dismissed an appeal from the High
Court's decision that both a patent on Levofloxacin (an anti
microbial pharmaceutical drug) and the supplementary protection
certificate (SPC) based on that patent were valid. The SPC had been
validly granted because Levofloxacin was a new product for the
purposes of the SPC Regulation, which was sufficiently clear and
therefore there was no need to refer questions to the ECJ.
For the full text of the...
To continue reading
Request your trial